Autopsy report · NCT05335707
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy
Cause of deathFunding or business
“Study funds ended on 7/31/2023”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- University of Kansas Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Urinary Bladder Cancer
- Participants
- 0
Trials that died the same way
- Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
“study funding period ended March 2022” - Abuse Potential of Buprenorphine/Naloxone
“Funding ended for the study” - Managing Chronic Tendon Pain by Metformin
“The study funding has ended.” - Field Administration of Stroke Therapy-Blood Pressure Lowering
“The funding period for the study has ended.” - Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
“funding for the study was terminated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.